Mavenclad 10 mg, Tabletten - 6 Swissmedic Key 66831003 Registration Holder Merck (Schweiz) AG Name Mavenclad 10 mg, Tabletten Date of registration 19.03.2019 Introduction of Sequence 19.03.2019 ATC-Classification Cladribine (L04AA40) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.99. Show package size 6 Index Therapeuticus (Swissmedic) 01.99. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 14089.14 Limitation Yes Limitation text
Deductible 10 % Consumer price 14701.70 Feedback FB Daily cost GTIN 7680668310036 Medication Code Synthetika Pharmacode 7721599 Disponibility
Composition cladribinum 10.00 mg, hydroxypropylbetadexum, sorbitolum 64.04 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Cladribine 10 mg
BAG: Active Agent Dose Cladribine 10 mg
Inactive agents Dose Hydroxypropylbetadexum Magnesii Stearas Pro Compresso Sorbitol 64.04 mg
Source Data was imported : 05.09.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
